Somatostatin receptor type 2 (SSTR2) knockout and antagonist blocked PACAP-induced inhibition of gastric acid secretion in mice

2003 ◽  
Vol 124 (4) ◽  
pp. A608
Author(s):  
Laura Piqueras ◽  
Yvette Tache ◽  
Vicente Martinez Sr.
1998 ◽  
Vol 114 (6) ◽  
pp. 1125-1132 ◽  
Author(s):  
Vicente Martinez ◽  
Annette P. Curi ◽  
Behrooz Torkian ◽  
James M. Schaeffer ◽  
Hilary A. Wilkinson ◽  
...  

Endocrinology ◽  
2007 ◽  
Vol 149 (2) ◽  
pp. 498-505 ◽  
Author(s):  
Chun-Mei Zhao ◽  
Vicente Martinez ◽  
Laura Piqueras ◽  
Lixin Wang ◽  
Yvette Taché ◽  
...  

The gastrin-enterochromaffin-like (ECL) cell-parietal cell axis is known to play an important role in the regulation of gastric acid secretion. Somatostatin, acting on somatostatin receptor type 2 (SSTR2), interferes with this axis by suppressing the activity of the gastrin cells, ECL cells, and parietal cells. Surprisingly, however, freely fed SSTR2 knockout mice seem to display normal circulating gastrin concentration and unchanged acid output. In the present study, we compared the control of acid secretion in these mutant mice with that in wild-type mice. In SSTR2 knockout mice, the number of gastrin cells was unchanged; whereas the numbers of somatostatin cells were reduced in the antrum (−55%) and increased in the oxyntic mucosa (35%). The ECL cells displayed a reduced expression of histidine decarboxylase and vesicle monoamine transport type 2 (determined by immunohistochemistry), and an impaired transformation of the granules to secretory vesicles (determined by electron microscopic analysis), suggesting low activity of the ECL cells. These changes were accompanied by an increased expression of galanin receptor type 1 in the oxyntic mucosa. The parietal cells were found to respond to pentagastrin or to vagal stimulation (evoked by pylorus ligation) with increased acid production. In conclusion, the inhibitory galanin-galanin receptor type 1 pathway is up-regulated in the ECL cells, and the direct stimulatory action of gastrin and vagal excitation is enhanced on the parietal cells in SSTR2 knockout mice. We suggest that there is a remodeling of the neuroendocrine mechanisms that regulate acid secretion in these mutant mice.


2005 ◽  
Vol 1039 (1-2) ◽  
pp. 75-83 ◽  
Author(s):  
Sachie Minowa ◽  
Satomi Ishihara ◽  
Shizuko Tsuchiya ◽  
Syunji Horie ◽  
Toshihiko Murayama

2000 ◽  
Vol 118 (4) ◽  
pp. A299
Author(s):  
Ming-Luen Doong ◽  
Hong Yang ◽  
Pu-Qing Yuan ◽  
Travis Solomon ◽  
Yvette F. Tache ◽  
...  

1995 ◽  
Vol 268 (1) ◽  
pp. G102-G106 ◽  
Author(s):  
K. C. Lloyd ◽  
J. Wang ◽  
K. Aurang ◽  
P. Gronhed ◽  
D. H. Coy ◽  
...  

Somatostatin is a potent inhibitor of gastric acid secretion. Recently, at least five distinct somatostatin receptor subtypes (SSTR) have been characterized and evaluated using relatively selective peptide analogues of somatostatin. We sought to determine which somatostatin receptor subtypes are involved in peripheral regulation of gastric acid secretion. Fasted, male Sprague-Dawley rats were anesthetized and were implanted with a double-lumen cannula in the stomach. Acid secretion was measured in gastric samples collected every 10 min by backtitration to pH 7. After a 30-min basal period, a 2-h intravenous infusion of pentagastrin (24 micrograms.kg-1.h-1 i.v.) was started. During the second pentagastrin hour, a 1-h intravenous infusion of either vehicle (0.1% canine serum albumin in 0.9% saline) or somatostatin receptor agonists was begun. The somatostatin receptor agonists included peptides with relative specificity for SSTR1-5 (somatostatin-14; 10 nmol.kg-1.h-1); SSTR2, SSTR3, and SSTR5 [SMS-(201-995); 10 nmol.kg-1.h-1]; SSTR2 (1-1,000 nmol.kg-1.h-1); SSTR3 (10-1,000 nmol.kg-1.h-1); and SSTR5 (10-1,000 nmol.kg-1.h-1). The SSTR2 agonist decreased pentagastrin-stimulated acid secretion dose dependently, from 82 +/- 7% of maximum acid output at 1 nmol.kg-1.h-1 to 4 +/- 7% of maximum at 100 nmol.kg-1.h-1. At 10 nmol.kg-1.h-1, the SSTR2 agonist inhibited acid secretion (40 +/- 7% of maximum) similarly to somatostatin (37 +/- 4% of maximum) and SMS-(201-995) (31 +/- 4% of maximum). The SSTR2 agonist inhibited acid secretion approximately 10- to 100-fold more potently than either the SSTR3 or the SSTR5 agonist. These results indicate that somatostatin regulates gastric acid secretion by activation of SSTR2 receptors.


Sign in / Sign up

Export Citation Format

Share Document